Kapron Injections for bleeding control 500 mg/5 ml, 6 ampoules; used for various bleeding conditions, whether post-surgical or due to certain health issues such as epistaxis (nosebleeds) or menorrhagia (heavy menstrual bleeding).
Ingredients of Kapron Injections
Kapron injections contain 500 mg/5 ml of the active ingredient "Tranexamic Acid," which is a competitive inhibitor of plasminogen activation. This means it interferes with the fibrinolytic process to stop bleeding.
What is the use of Kapron Injection?
Kapron injections are used in cases of hemorrhage or increased risk of bleeding due to increased fibrinolysis or fibrinogenolysis. Local fibrinolysis may increase in cases of:
-
Prostatectomy and bladder surgeries.
-
Menorrhagia (heavy periods).
-
Epistaxis (nosebleeds).
-
Conisation of the cervix.
-
Management of dental extractions in patients with blood clotting disorders.
-
Ulcerative colitis.
-
Hematuria (blood in the urine); however, it is not used for hematuria caused by diseases of the renal parenchyma.
-
Gastrointestinal bleeding.
As for generalized fibrinogenolysis, it may occur in prostate and pancreatic cancer, and after thoracic and major surgeries, such as:
-
Certain childbirth complications.
-
Leukemia.
-
Liver disease.
Kapron Injection Dosage and Administration
-
The appropriate dosage of Kapron injections is determined by the physician.
-
Kapron is administered via intravenous (IV) injection.
Kapron 500 mg Side Effects
-
Nausea.
-
Vomiting.
-
Diarrhea.
Contraindications
Kapron injections should not be used in cases of:
-
Hypersensitivity to any of its ingredients.
-
A medical history or increased risk of thrombosis (clots), unless anticoagulant medication can be administered concurrently.
-
Deep Vein Thrombosis (DVT).
-
Pulmonary Embolism.
-
Cerebral arterial thrombosis.
-
Impaired color vision.
-
Subarachnoid hemorrhage.
Storage and Handling
-
Store at a temperature not exceeding 25°C.
-
Protect from light.
-
Do not freeze.
